跳至主要内容
临床试验/NCT00783731
NCT00783731已完成不适用

Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)

Seoul National University Hospital2 个研究点 分布在 1 个国家开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
2

研究概览

简要总结

Midazolam has been used in rapid sequence intubation for a long time, and the recommended dose is 0.1mg/kg. In some studies, however, the reduced dose has been used with the concern of hemodynamic instability. We would like to investigate that the low dose midazolam could be used rather than the standard recommended dose, and also compare it to the etomidate, recently used sedatives, with respect to the side effects and the easy performance of intubation.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who need rapid sequence intubation in emergency room

排除标准

  • in hypotension(systolic blood pressure less than 90 mmHg
  • severe trauma patients
  • allergic to midazolam, etomidate

研究组 & 干预措施

Low dose midazolam

Experimental

干预措施: Low dose midazolam (Drug)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Low Dose of Midazolam is Superior to Conventional... | 临床试验